KPV Capsules and Creams Compounded

Compounded KPV peptide prepared to your prescriber’s specifications by CareFirst Specialty Pharmacy, a PCAB-accredited 503A compounding pharmacy licensed to dispense in all 50 states. Available as oral capsules (250mcg, 500mcg and 1000mcg) and as a topical cream (0.01% and 0.1%) with a valid prescription.

Key Facts

Dosage forms	Oral capsules · Topical cream
Capsule strengths	250mcg · 500mcg · 1000mcg
Capsule quantities	30 · 60 · 90 · 100
Cream strengths	0.01% · 0.1% — Get Quote for custom strengths
Cream sizes	30gm · 60gm · 90gm
Price	Capsules from $39.95 · Cream from $59.95
Prescription	Required (patient-specific)
FDA status	Not FDA approved (see regulatory status below)
Ships to	All 50 states

Key Takeaways

• KPV is a three-amino-acid peptide (lysine-proline-valine), the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH).
• CareFirst compounds KPV as oral capsules and as a topical cream. Your prescriber chooses the form.
• Published KPV research is mostly cell and animal studies. Controlled human trial data are limited.
• On October 28, 2026, HHS announced it will not take enforcement action against licensed compounding pharmacies making KPV while formal rulemaking continues. This is not FDA approval.
• KPV is not a replacement for prescribed treatment of inflammatory bowel disease or any other condition.
• Your prescriber decides the strength and schedule.

What Is KPV Peptide?

KPV is a short peptide made of three amino acids: lysine, proline and valine (Lys-Pro-Val). It is the C-terminal fragment (amino acids 11–13) of alpha-melanocyte-stimulating hormone (α-MSH), a hormone the body produces naturally. Researchers isolated this fragment because, in laboratory and animal models, it appears to carry much of the inflammation-related signaling activity of α-MSH without the full hormone’s pigment-stimulating activity.

Like BPC-157 and Semax, KPV is a peptide, meaning a chain of amino acids. At only three amino acids, it is one of the smallest peptides CareFirst compounds, which is part of why it can be prepared for both oral and topical use.

What Is KPV Used For?

KPV has been studied in laboratory and animal research for its role in inflammatory signaling, mainly in models of intestinal inflammation (such as experimental colitis) and in skin cell research. It is not FDA approved to treat any condition.

Online, KPV is widely discussed for gut and skin concerns. Those claims are not supported by well-designed human trials, and CareFirst does not make treatment claims about KPV. Whether KPV is appropriate for you is a decision for your prescriber.

How Does KPV Work?

The exact way KPV acts in people is not fully understood. In cell studies, KPV has been reported to interfere with NF-κB, a protein complex that regulates many inflammatory signaling genes. A 2008 review in Endocrine Reviews summarized laboratory and animal research on α-MSH and related tripeptides, including KPV.

Animal findings do not always carry over to humans, so these results describe what researchers are studying, not what KPV will do for any individual patient.

Capsules vs. Cream: Choosing a Form

The form a prescriber chooses usually depends on where the medication is meant to act. KPV is small enough to be prepared for oral or topical use, and the two forms reach different tissues.

How Oral KPV Reaches the Gut

Most peptides break down in the digestive tract before they can do much. KPV has drawn research interest because, as a tripeptide, it is a substrate for PepT1, a transporter on intestinal cells that normally absorbs di- and tripeptides from food. In a 2008 mouse study published in Gastroenterology, researchers reported that KPV was taken up into intestinal cells through PepT1 and reduced inflammation in mouse models of colitis. Later animal studies explored nanoparticle delivery systems to target KPV to the colon.

These are animal findings and have not been confirmed in human trials.

What the Research Shows, and What It Doesn’t

• What we know: KPV is a well-characterized fragment of α-MSH, it is absorbed by the intestinal PepT1 transporter in animal studies, and it has been studied in cell and animal models of intestinal and skin inflammation.
• What we don’t know: optimal dosing in people, long-term safety, effectiveness for the uses people search for online, and how KPV interacts with other medications or conditions.

KPV Side Effects and Safety

Human safety data for KPV are limited. Reported issues include mild nausea or stomach upset with oral forms and local skin irritation with topical forms. Because large, long-term safety studies have not been done, the full side-effect profile is not known.

KPV Dosage

CareFirst does not recommend doses. Your prescriber chooses the form, strength, how often to take or apply it, and for how long. Those directions will appear on your prescription label.

Dosing charts posted online often come from “research peptide” sellers or forums and are not a substitute for your prescriber’s directions. If your prescriber needs a strength we don’t list, we can prepare a custom quote.

KPV and the FDA: Where Things Stand in 2026

July 2026	FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding KPV to the Section 503A Bulk Drug Substances List.
October 14, 2026	HHS sent an “Interim Access Policy for Compounding Using Certain Peptides” to the White House Office of Management and Budget for review.
October 28, 2026	HHS issued a notice exercising “enforcement discretion”: FDA will not pursue legal action against state-licensed compounding pharmacies and physicians making six peptides (KPV, BPC-157, TB-500, MOTS-c, Semax and Epitalon), even though they are not yet on the 503A Bulk Drug Substances List.
Next	Formal rulemaking on adding KPV to the 503A Bulk Drug Substances List continues separately, including a proposed rule and public comment period.

What enforcement discretion means, and what it doesn’t

Enforcement discretion means FDA has said it will not take legal action against 503A pharmacies and physicians that compound KPV under the terms of the notice. It does not change the underlying law.

• It is not FDA approval. KPV remains legally an “unapproved drug.”
• It does not add KPV to the 503A Bulks List. That decision still depends on the separate rulemaking process.
• It is an interim policy. HHS can revise or withdraw it later.

Some details of the notice, including the specific sourcing, certification, and adverse-event reporting conditions pharmacies must meet, have not yet been confirmed.

For background on the July 2026 advisory vote, see Recent Developments on Peptide Use & Approval.

KPV vs. BPC-157

KPV and BPC-157 are often searched together, and prescribers sometimes write for both. They are different molecules: KPV is a three-amino-acid fragment of α-MSH, while BPC-157 is a fifteen-amino-acid synthetic peptide. Both are covered by the same October 2026 HHS notice, and CareFirst compounds both as oral capsules. Whether to use one, both or neither is your prescriber’s decision.

“Research Peptides” vs. a Compounding Pharmacy

Search for “buy KPV” and you’ll find many websites selling capsules, creams and powders labeled “for research use only” or “not for human consumption.” Those products are not prepared under pharmacy standards, are not dispensed against a prescription, and are not checked by a pharmacist for your situation.

When you fill a prescription with CareFirst Specialty Pharmacy:

• Your medication is compounded for you, by a licensed pharmacy, from a patient-specific prescription.
• We are a PCAB-accredited 503A compounding pharmacy licensed to ship to all 50 states.
• A pharmacist reviews your prescription and is available to answer questions.
• Our quality processes are documented on our Commitment to Quality page.

Not sure who is actually making the medication you buy online? Read Who actually makes your compounded medication?

How to Get KPV from CareFirst

1. Talk with your prescriber. They decide whether KPV is appropriate and which form and strength to prescribe.
2. Send us the prescription. Your prescriber can fax, phone in, or e-prescribe to CareFirst Specialty Pharmacy (Mount Laurel, NJ · NCPDP #3151266). You can also register as a patient or transfer a prescription, and we can contact your prescriber for you.
3. We compound and ship. See How to Order and Shipping Info for timelines and delivery options.

Prescribers: write “Compounded Medication” followed by KPV, the dosage form (capsule or topical cream), strength, quantity and directions for use. Our pharmacists can prepare custom cream strengths on request. Visit our Prescribers page to send scripts or request more information.

Frequently Asked Questions

What is KPV peptide?

KPV is a three-amino-acid peptide (lysine-proline-valine). It is the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), a hormone the body makes naturally. CareFirst compounds KPV as oral capsules and as a topical cream.

What is KPV peptide used for?

KPV has been studied in laboratory and animal research for its role in inflammatory signaling, including models of intestinal and skin inflammation. It is not FDA approved to treat any condition. Your prescriber decides whether it is appropriate for you and which form to use.

Is KPV FDA approved?

No. KPV is not an FDA-approved drug in any form, and compounded medications are not FDA approved. On October 28, 2026, HHS issued a notice of enforcement discretion stating that FDA will not pursue legal action against compounding pharmacies and physicians making KPV and five other peptides while formal rulemaking continues. This is not FDA approval, and the notice is an interim policy that HHS can revise or withdraw.

Can a compounding pharmacy legally make KPV?

Under the October 2026 HHS notice, state-licensed 503A compounding pharmacies may prepare KPV for an individual patient with a valid prescription without facing FDA enforcement action while formal rulemaking continues. CareFirst is a 503A pharmacy licensed in all 50 states and compounds KPV only against a valid prescription.

What KPV strengths does CareFirst offer?

Oral capsules are available in 250mcg, 500mcg and 1000mcg. Topical cream is available in 0.01% and 0.1%, and custom cream strengths can be prepared on prescriber request.

Should I use KPV capsules or cream?

That depends on where your prescriber intends the medication to act. Capsules pass through the digestive tract, while cream is applied to a specific area of skin. Your prescriber chooses the form, strength and directions.

Do I need a prescription for KPV?

Yes. CareFirst compounds KPV only for patients with a valid, patient-specific prescription. Products sold online as “for research use only” are not prepared for patient use and are not dispensed by a licensed pharmacy.

What are the side effects of KPV?

Human safety data are limited. Mild nausea or stomach upset has been reported with oral forms, and local skin irritation is possible with topical forms. Report any side effects to your prescriber and our pharmacy.

Is KPV safe for people with a history of cancer?

This has not been studied in people. Animal research has examined the intestinal transporter KPV uses in the setting of colitis-associated cancer. If you have current or past cancer, talk with your oncologist and prescriber before starting KPV.

Does KPV replace my IBD medication?

No. KPV is not an approved treatment for Crohn’s disease, ulcerative colitis or other inflammatory bowel conditions and should not replace prescribed therapy. Any use should be coordinated with your treating specialist.

Can KPV be prescribed with BPC-157?

Prescribers sometimes write for both. They are different peptides: KPV is a three-amino-acid fragment of α-MSH, while BPC-157 is a fifteen-amino-acid peptide. Both are covered by the same October 2026 HHS notice. CareFirst also compounds BPC-157 capsules. Whether to use one, both or neither is your prescriber’s decision.

Will KPV affect skin color?

KPV is the fragment of α-MSH that researchers studied specifically because it lacks the full hormone’s pigment-stimulating activity. Ask your prescriber or our pharmacists if you have questions about your skin.

How much does compounded KPV cost?

KPV capsules start at $39.95 for 30 capsules of 250mcg, and KPV cream starts at $59.95 for 30gm of 0.01%. Compounded peptides are generally not covered by insurance. Please contact us for the most current pricing.

References

1. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178.
2. Brzoska T, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews. 2008;29(5):581–602.
3. Viennois E, et al. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cell Mol Gastroenterol Hepatol. 2016;2(3):340–357.
4. Xiao B, et al. Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis. Molecular Therapy. 2017;25(7):1628–1640.
5. U.S. Department of Health and Human Services notice of enforcement discretion for six compounded peptides, October 28, 2026, as reported by NBC News and STAT.
6. McDermott Will & Schulte. “Bulk-list bound? PCAC backs majority of peptides in two-day public meeting.” July 2026. mcdermottlaw.com

Disclaimer